| Dose
|
Single Dose
|
Frequency
|
Route
|
Instructions
|
Adult Dosage
|
| 0 to 50 mg | 25 (25) | As recommended. | PO | Patients infected with HIV-1 without suspected resistance to the integrase class |
| 50 mg | 50 (50) | As recommended. | PO | patient infected with HIV-1 without suspected resistance to the integrase classwhen co-administered with some medicines (e.g. efavirenz, nevirapine, tipranavir/ritonavir, or rifampicin) i |
| 50 mg | 50 (50) | As recommended. | PO | Patients infected with HIV-1 with resistance to the integrase class |
Paedriatic Dosage (20kg)
|
| 0 to 50 mg | 25 (25) | As recommended. | PO | pediatric patients aged 12 years and older and weighing at least 40 kg |
Neonatal Dosage (3kg)
|
| No data regarding the neonatal dosage details of Dolutegravir is available. |